申请人:Universidad de Barcelona
公开号:EP1553080A1
公开(公告)日:2005-07-13
Serratamolide, also named cyclo[(3R)-3-hydroxydecanoyl-L-seryl-(3R)-3-hydroxydecanoyl-L-seryl], is a cyclic depsipeptide isolated from cultures of bacteria of the species Serratia marcescens. Serratamolide decreases the viability of, and induces apoptosis in several cancer cells (leukemias, myelomas, carcinomas, etc.), virtually with no effect on non-cancer cells. This makes serratamolide, and its pharmaceutically acceptable addition salts and/or solvates, useful as anticancer chemotherapeutic agent, particularly against leukemia, lymphoma, myeloma, carcinoma, melanoma and sarcoma.
Serratamolide 又名环[(3R)-3-羟基癸酰基-L-丝氨酰-(3R)-3-羟基癸酰基-L-丝氨酰],是从 Serratia marcescens 菌种的培养物中分离出来的一种环状去肽。沙拉他莫利内酯可降低多种癌细胞(白血病、骨髓瘤、癌等)的活力并诱导其凋亡,但对非癌细胞几乎没有影响。因此,丝裂莫来及其药学上可接受的加成盐和/或溶解物可用作抗癌化疗剂,特别是针对白血病、淋巴瘤、骨髓瘤、癌、黑色素瘤和肉瘤。